Skip to main content
Premium Trial:

Request an Annual Quote

So Much on Its Plate

The Medical Writing, Editing & Grantsmanship reminds us all that there might be some re-organization going on at NIH. The Scientific Management Review Board, selected by Elias Zerhouni before his resignation last October, met to ponder the possibility that the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse should merge, and also whether the structure of intramural research at NIH, including the clinical center, should be reviewed. The board decided that the plans merited further study.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.